BR100 Increased By (0.09%)
BR30 Increased By (0.15%)
KSE100 Increased By (0.32%)
KSE30 Increased By (0.34%)
AGHA 6.52 Increased By ▲ 0.20 (3.16%)
BECO 4.39 Increased By ▲ 0.12 (2.81%)
BML 62.46 Increased By ▲ 0.01 (0.02%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.78 Increased By ▲ 0.19 (1.64%)
CSIL 6.00 Increased By ▲ 0.28 (4.9%)
FCCL 60.80 Decreased By ▼ -0.74 (-1.2%)
FFL 14.93 Decreased By ▼ -0.09 (-0.6%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.28 Increased By ▲ 0.02 (0.32%)
KOSM 5.80 Increased By ▲ 0.24 (4.32%)
LOTCHEM 24.76 Increased By ▲ 0.08 (0.32%)
MLCF 103.10 Decreased By ▼ -0.98 (-0.94%)
NBP 174.45 Decreased By ▼ -0.83 (-0.47%)
NCPL 53.00 Increased By ▲ 0.23 (0.44%)
NPL 54.65 Increased By ▲ 0.53 (0.98%)
OGDC 314.69 Increased By ▲ 1.30 (0.41%)
PACE 9.40 Increased By ▲ 0.20 (2.17%)
PAEL 35.50 Decreased By ▼ -0.30 (-0.84%)
PIBTL 13.66 Increased By ▲ 0.19 (1.41%)
PPL 221.94 Increased By ▲ 0.13 (0.06%)
PRL 80.77 Increased By ▲ 1.69 (2.14%)
PTC 47.00 Increased By ▲ 0.15 (0.32%)
SSGC 24.14 Increased By ▲ 0.27 (1.13%)
TBL 9.22 Decreased By ▼ -0.09 (-0.97%)
TELE 7.46 Increased By ▲ 0.07 (0.95%)
TPL 24.75 Decreased By ▼ -0.36 (-1.43%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.00 Decreased By ▼ -0.25 (-0.95%)
TRG 53.99 Increased By ▲ 0.55 (1.03%)
World

Japan says vaccination schedule for broader population undecided

  • Chief Cabinet Secretary Katsunobu Kato made the comment at a news conference in response to a question about media reports that the government was considering doing so as early as in May.
Published Updated
By

TOKYO: Japan's top government spokesman said on Wednesday that the timeline for vaccinating the broader population against the coronavirus would be decided and disclosed to the public after the approval of a vaccine.

Chief Cabinet Secretary Katsunobu Kato made the comment at a news conference in response to a question about media reports that the government was considering doing so as early as in May.

The government has so far said it would prioritise medical workers, the elderly, and those with pre-existing conditions in its vaccine programme expected to start by the end of February, but has not provided a timeline beyond that.

Comments

Comments are closed for this article.